latest newsRead more...
21
Apr 2018Biogen and Ionis Expand Strategic Collaboration to Develop Drug Candidates for a Broad Range of Neurological Diseases
Biogen and Ionis Pharmaceuticals announced they have expanded their strategic collaboration through a new tenyear collaboration agreement to develop novel antisense drug candidates for a broad range of neurological diseases This collaboration capitalizes on Biogens expertise in neuroscience research and drug development and Ionis leadership…
20
Apr 2018Tocagen and ApolloBio Enter License Agreement to Develop and Commercialize Toca 511 & Toca FC
Tocagen Inc a clinicalstage cancerselective gene therapy company and Beijing Apollo Venus Biomedical Technology Limited an affiliate of ApolloBio Corp NEEQ a biopharmaceutical company focused on oncology collectively ApolloBio today announced they have entered into a license agreement providing ApolloBio with an exclusive license to…
20
Apr 2018bioGO™ Introduces 'BioProduction Agility' to Accelerate Biotech Innovation
Germfree has released bioGO this week in New York at INTERPHEX The biomanufacturing platform represents a completely new approach to quick and flexible production space The company created bioGO in response to limited and rigid infrastructure options for launching biopharmaceutical projects The Adaptive Platform delivers…
press releasesRead more...
21
Apr 2018Merck Foundation and Tata Memorial Centre Signs MoU to Build Cancer Care Capacity in Africa
Business Wire IndiaDr Rasha Kelej CEO of Merck Foundation with the future oncologists of Africa getting trained at the Tata Memorial Centre in MumbaiDr Rasha Kelej CEO Merck Foundation and…
21
Apr 2018Iterum Therapeutics Presents Data on Prevalence of Resistant Infections and Activity of its Novel Antibiotic Sulopenem
Iterum Therapeutics plc a clinicalstage pharmaceutical company developing antiinfectives against multidrug resistant pathogens will deliver a minioral presentation and two additional posters at the European Congress of Clinical Microbiology in…
21
Apr 2018Phenomenex Introduces bioZen™ Series for Characterization of Biotherapeutics
Phenomenex Inc a global leader in the research and manufacture of advanced technologies for the separation sciences introduces bioZen a new series of LC solutions for bioseparations in pharmaceutical biopharmaceutical…
EventsRead more...
23-25
Apr 20188th Annual Strategic Alliance Management for Pharma
marcus evans
Berlin
23-26
Apr 2018Vaccine Manufacturing 2018
KNect365 Life Science
Amsterdam RAI Exhibition and Convention Centre
TOP ARTICLES
-
1
Cancer Stem Cell (CSC) Inhibitors
Cancer as a group of heterogeneous diseases very well known Unimaginable amounts of money and manhours have been spent in finding cure for this deadly disease H..
-
2
Enhancement of the Aqueous Solubility and Permeability of Poorly Water- Soluble Drugs
Introduction Combinatorial chemistry High Throughput Screening technique HTS and other computeraided methods have proved their usefulness for drug design and..
-
3
Blood-Brain Barrier and CNS Drug Delivery
Introduction The idea of Blood Brain Barrier BBB dates back to more than years ago when Paul Erlich observed that by intravenous injection of certain dyes all..
-
4
Nanocomposite Hybrid Metal-Organic Framework in Drug Delivery and Theranostic application
Introduction MOFs are evolving novel hybrid materials comprised of two component of inorganic and an organic fraction with diverse physicochemical characteris..
-
5
Nanotherapeutic Intervention in Cancer Disease
Introduction Cancer is second most prevalent and lethal disease after cardiovascular disorder despite of advances in tumor biology research and chemotherapy Th..
-
6
Mesoporous Silica Nanoparticles
Mesoporous Silica Nanoparticles MSNs have attracted great attention over the last decade as a drug delivery system in the fields of biotechnology and Nano medic..
Knowledge Bank
-
Interviews
European Lead Factory
Head of European Screening Centre
Ton Rijnders is the Head of Screening at the European Lead Factory He holds a PhD in molecular biology and has an extensive experience with drug discovery in pharma with increasing managerial and scientific responsibilities Since November Ton is the..
-
Articles
Cancer Stem Cell (CSC) Inhibitors
Cancer as a group of heterogeneous diseases very well known Unimaginable amounts of money and manhours have been spent in finding cure for this deadly disease Howeverit still remains in the top five list of diseases affecting mankind Millions of patients suffer worldwide every single day hoping to get cured Most of them lose…
-
Research Insights
Clonal Evolutionary Analysis during HER2 Blockade in HER2-Positive Inflammatory Breast Cancer: A Phase II Open-Label Clinical Trial of Afatinib +/- Vinorelbine
Abstract Background Inflammatory breast cancer IBC is a rare aggressive form of breast cancer associated with HER amplification with high risk of metastasis and an estimated median survival of y We performed an openlabel singlearm phase II clinical trial ClinicalTrialsgov NCT to investigate the efficacy and safety of afatinib an irreversible ErbB family inhibitor alone and in combination with vinorelbine…
-
Case Studies
Rapid, Comprehensive, And Aff Ordable Mycobacterial Diagnosis With Whole-genome Sequencing: A Prospective Case Study
Abstract Background Slow and cumbersome laboratory diagnostics for Mycobacterium tuberculosis complex MTBC risk delayed treatment and poor patient outcomes Wholegenome sequencing WGS could potentially provide a rapid and comprehensive diagnostic solution In this prospective study we compare realtime WGS with routine MTBC diagnostic workflows Methods We compared…
-
Techno Trends
Cipher Pharmaceuticals Launches a Novel Bactericidal Topical Antibiotic Cream in Canada
Cipher Pharmaceuticals Inc announced the Canadian launch of OZANEX ozenoxacin cream a novel bactericidal topical antibiotic cream indicated for the treatment of impetigo in patients aged months and older OZANEX can be used to cure one of the most common and contagious bacterial skin infections It can be utilised as a new and important treatment alternative for skin infections The…
-
White Papers
Launching Global Clinical Trials—best Practices For Efficient And Cost-effective Translations: A Lionsbridge White Paper
Summary The target market for conducting global clinical trials has changed significantly moving beyond pharmaceutical early adopters to the mainstream marketplace This shift has placed a heightened focus on the language challenges and complexity of running a global clinical trial More and more companies are moving toward ascending regions such as India and China to…
-
Industry Reports
Sanochemia Pharmazeutika AG (SAC) - Financial and Strategic SWOT Analysis Review
Sanochemia Pharmazeutika AG Sanochemia is a specialty pharmaceutical company that develops and manufactures of innovative drugs and diagnostics in selected indication areas such as neurodegeneration pain and cancer as well as diagnostic products based on contrast media The companys product portfolio includes radiological products including an array of xray imaging…
Advisory Board
Editorial Section
-
Strategy
Globalisation
As the pharmaceutical industry squares off against the challenge of globalisation there is a greater need for content than ever Driven by forces from both the clinical and commercial sides pharmaceutical companies are experiencing rising costs and competition Ultimately to…
-
Research development
Knowing vs Hunting for Targets
Selecting a target for settingup the drug discovery path is a tough decision and often this choice is based on borrowed and incomplete knowledge from the literature In many cases this has led to serious challenges in the late stages…
-
Clinical Trials
Use of Real World Evidence
Real World Evidence RWE can be used to inform decisions throughout the life cycle of a drug from development through postapproval Across Asia many countries have begun incorporating real world evidence and while some are fast adopters in terms of…
-
Manufacturing
Cultural Excellence as the Foundation
In pharmaceutical companies it is universally understood that a robust Pharmaceutical Quality System PQS provides key elements of assurance and oversight for pharmaceutical manufacturing and quality control laboratory processes However despite recent advances in the…
-
Information Technology
Electronic FDA Submissions
If your time to you is worth savin then you better start swimmin or youll sink like a stone for the times they are a changin Bob Dylan
-
Expert Talk
Pushing the Limits of Temperature Control
Todays pharmaceutical environment has become increasingly complex with more specialty products like biologics injectable and clinical trial drugs being shipped than ever The industry standard for commercial packaging is hours which is no longer always…